Loopback Analytics Welcomes Elizabeth Cherry as New VP of Access Solutions

Loopback Analytics is thrilled to announce the addition of Elizabeth Cherry as its new Vice President of Access Solutions. With a robust background in specialty pharmacy and market access strategies, Cherry is set to bring innovative solutions that will further enhance Loopback's mission to break down barriers that patients face in accessing crucial medications.

A Leader in Specialty Pharmacy

Elizabeth Cherry comes to Loopback from her most recent role as Senior Director of Trade Relations and Market Access at Vanderbilt Specialty Pharmacy. During her tenure, she played a significant role in aligning manufacturers, payors, and health systems, which improved the accessibility of high-cost, complex medications. Cherry’s work garnered nationwide recognition for creating frameworks that facilitate collaborative access models, ultimately enhancing patient outcomes.

Neil Smiley, CEO of Loopback, expressed confidence in Cherry's capabilities: "Elizabeth combines strategic insight with operational depth. Her leadership will be instrumental in helping Loopback strengthen its network and deliver measurable value to both our life sciences partners and the health systems we support."

Expanding Access to Limited Distribution Drugs

At Vanderbilt, Cherry was pivotal in expanding access to limited distribution drugs (LDDs). She meticulously crafted legal, operational, and data frameworks that fostered long-term partnerships between manufacturers and integrated delivery networks (IDNs). This alignment was designed to not only meet manufacturer goals but also to enhance the infrastructure of health systems, thereby generating a significant real-world impact.

Cherry is a recognized expert in her field, often sharing her insights as a speaker at major conferences like Asembia, NASP, and the IDN Bio/Pharma Partnering Summit. Her thought leadership focuses on dismantling silos between life sciences and provider systems, with published works that advocate for outcomes-driven models that benefit patients and the entire specialty pharmacy ecosystem.

A Commitment to Dismantling Barriers

In her own words, Cherry stated, "I’ve dedicated my career to dismantling access barriers in specialty pharmacy. Joining Loopback is an opportunity to scale those efforts—to help health systems thrive while supporting manufacturers in connecting patients to life-changing therapies."

Cherry's appointment underscores Loopback's ongoing commitment to empower health system specialty pharmacies. This is achieved through providing the necessary infrastructure and insights to enhance their role as high-performing partners within the industry.

For life sciences organizations inspired to explore innovative access strategies, Loopback Analytics offers a wealth of resources and collaboration opportunities.

About Loopback Analytics

Loopback Analytics serves as a bridge between health systems and life sciences companies, enabling enhanced access, improved performance, and better patient outcomes in specialty care. The company provides health systems with data-driven insights and services that empower specialty pharmacy leaders to optimize their operations and unlock market access. Meanwhile, it offers life sciences companies detailed real-world data and scalable health system channel solutions that expedite evidence generation and create effective patient access strategies. Through collaboration, Loopback Analytics transforms data into actionable insights, fostering progress for both patients and healthcare partners.

For more information about Loopback Analytics and its services, visit www.loopbackanalytics.com.